dehydroepiandrosterone has been researched along with ribose-5-phosphate in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Braunstein, LD; Pang, J; Stanton, RC; Stuhlmeier, KM; Tian, WN; Tian, X; Xi, QC | 1 |
Giaume, C; Jiménez, C; Medina, JM; Tabernero, A; Velasco, A | 1 |
Bassilian, S; Cascante, M; Centelles, JJ; Ciudad, CJ; Kazhyna, MV; Lee, WN; Lim, S; Noé, V; Ramos-Montoya, A; Trebukhina, RV | 1 |
3 other study(ies) available for dehydroepiandrosterone and ribose-5-phosphate
Article | Year |
---|---|
Importance of glucose-6-phosphate dehydrogenase activity for cell growth.
Topics: 3T3 Cells; Animals; Cell Division; COS Cells; Dehydroepiandrosterone; Enzyme Inhibitors; Glucosephosphate Dehydrogenase; Mice; NADP; Oxidation-Reduction; Phosphorylation; Ribosemonophosphates; Thymidine; Tyrosine | 1998 |
The enhancement of glucose uptake caused by the collapse of gap junction communication is due to an increase in astrocyte proliferation.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Arachidonic Acid; Astrocytes; Biological Transport; Cell Communication; Cell Division; Cells, Cultured; Culture Media, Serum-Free; Cytarabine; Cytochalasin B; Dehydroepiandrosterone; Endothelin-1; Enzyme Inhibitors; Gap Junctions; Glucose; Glycyrrhetinic Acid; Hypoglycemic Agents; Ouabain; Pentose Phosphate Pathway; Rats; Rats, Wistar; Ribosemonophosphates; Tolbutamide | 2001 |
Pentose phosphate cycle oxidative and nonoxidative balance: A new vulnerable target for overcoming drug resistance in cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Ehrlich Tumor; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dehydroepiandrosterone; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Synergism; Growth Inhibitors; HT29 Cells; Humans; Methotrexate; Mice; Mice, Inbred BALB C; Nucleic Acid Synthesis Inhibitors; Oxidation-Reduction; Oxythiamine; Pentose Phosphate Pathway; Ribosemonophosphates | 2006 |